Established a collaborative research center on campus with the Hayashi Lab of Institute of Science Tokyo in April 2019. AI can accurately determine protein mutations based on digital images of human and animal proteins (hereinafter referred to as proteomics images), enabling early search for biomarker candidates at drug discovery sites and obtaining evidence on the efficacy of substances. In November 2023, we will establish our own research base, the Proteomics Innovation Center (PIC), and build a system to promote biomarker exploration for external collaborations, drug discovery support, early diagnosis for humans and animals, and quality & safety improvement for agriculture and livestock, as well as their research planning, design, and customer proposals in an integrated manner.

In the future, AI proteomics technology will be introduced as a primary screening before health checkups, and appropriate workups will be encouraged to reduce diagnostic costs. Ultimately, we aim to apply this technology to sensor technology that allows easy and easy testing anytime and anywhere, and enables early detection of diseases and injuries, so that preventive measures can be taken while healthy.